Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The Clinical Efficacy and Safety of Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, in Primary Sjogren's Syndrome: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Trial St Clair, E., Baer, A. N., Noaiseh, G., Parke, A., Coca, A., Utset, T., Genovese, M. C., Wallace, D. J., McNamara, J., Boyle, K., Keyes-Elstein, L., Franchimont, N., James, J. A., Autoimmunity Ctr Excellence WILEY-BLACKWELL. 2015
View details for Web of Science ID 000370860204752